Covid-19 Immunisation
- All
- News
- Videos
-
Focus On Unvaccinated Children, Strengthen Routine Immunisation Capacities: WHO
The regional director emphasised the need for periodic mapping of at-risk populations and for developing actionable plans to address gaps in immunisation.
-
Mobile 3D Printer to Produce Thumbnail-Sized mRNA Covid Vaccine Patches Developed by Scientists: Details
A mobile 3D printer to produce thumbnail-sized patches capable of delivering mRNA Covid vaccines has been developed by scientists. The device is likely years away from being available and many hurdles remain, but the tabletop device could help immunise people in remote regions. A 3D printer can create two-centimetre-wide vaccine patches with hundre...
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
Thailand Reverses Covid Vaccination Entry Rule For Visitors
Thailand has rescinded an entry policy announced at the weekend requiring visitors to show proof of a COVID-19 vaccination, its health minister said on Monday, citing sufficient immunisation levels in China and globally.
-
Can't Be Liable To Compensate For Deaths Due To Covid Vaccines: Centre To Supreme Court
The government cannot be held liable to compensate for the deaths due to an adverse event following immunisation (AEFI) post administration of Covid-19 vaccines, the Centre has told the Supreme Court.
-
New Nasal Vaccine Against Covid-19: Your 5-Point Guide
A nasal vaccine against Covid-19, iNCOVACC, developed by Bharat Biotech, has been approved by India's Central Drugs Standard Control Organisation. This is India's first intra-nasal vaccine against Covid-19
-
Compensate Families Of Those Dead Due To Covid Vaccine Side Effects: Court
The Kerala High Court has directed the National Disaster Management Authority (NDMA) to "expeditiously" frame a policy for identifying those who died due to after effects of COVID-19 immunisation and compensating their dependents.
-
Death Rates Low Despite Rise In Covid Cases Due To Vaccination: Centre
The COVID-19 case trajectory in some states is witnessing an upward trend since May but hospitalisation and death rates are low which can be attributed to immunisation efforts across India, the Lok Sabha was told Friday.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
-
"Reports That Expired Covid Shots Being Given False, Misleading": Centre
Reports claiming that expired vaccines in the 15 to 18 age group are being given under national COVID-19 vaccination programme are false and misleading, the government clarified today, adding that the reports used "incomplete information".
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Europe Ramps Up Covid Vaccine Drive For Children Under 5 As Omicron Spreads
Europe stepped up vaccinations of children aged five to 11 against Covid-19 Wednesday, as the EU's health agency warned that immunisation alone would not stop the rapid rise of the Omicron variant of the virus.
-
Senegal Expects 400,000 Covid Vaccine Doses To Be Wasted By End-December
At least 200,000 COVID-19 vaccines have expired in Senegal without being used in the past two months and another 200,000 are set to expire at the end of December because demand is too slow, the head of its immunisation programme said on Monday.
-
Focus On Unvaccinated Children, Strengthen Routine Immunisation Capacities: WHO
The regional director emphasised the need for periodic mapping of at-risk populations and for developing actionable plans to address gaps in immunisation.
-
Mobile 3D Printer to Produce Thumbnail-Sized mRNA Covid Vaccine Patches Developed by Scientists: Details
A mobile 3D printer to produce thumbnail-sized patches capable of delivering mRNA Covid vaccines has been developed by scientists. The device is likely years away from being available and many hurdles remain, but the tabletop device could help immunise people in remote regions. A 3D printer can create two-centimetre-wide vaccine patches with hundre...
-
Jharkhand Seeks 50,000 Covid Vaccine Doses From Centre As Cases Rise
Amid rising cases of coronavirus, Jharkhand Health Minister Banna Gupta urged the Centre to provide at least 50,000 COVID-19 vaccine doses to continue with the immunisation drive in the state.
-
Thailand Reverses Covid Vaccination Entry Rule For Visitors
Thailand has rescinded an entry policy announced at the weekend requiring visitors to show proof of a COVID-19 vaccination, its health minister said on Monday, citing sufficient immunisation levels in China and globally.
-
Can't Be Liable To Compensate For Deaths Due To Covid Vaccines: Centre To Supreme Court
The government cannot be held liable to compensate for the deaths due to an adverse event following immunisation (AEFI) post administration of Covid-19 vaccines, the Centre has told the Supreme Court.
-
New Nasal Vaccine Against Covid-19: Your 5-Point Guide
A nasal vaccine against Covid-19, iNCOVACC, developed by Bharat Biotech, has been approved by India's Central Drugs Standard Control Organisation. This is India's first intra-nasal vaccine against Covid-19
-
Compensate Families Of Those Dead Due To Covid Vaccine Side Effects: Court
The Kerala High Court has directed the National Disaster Management Authority (NDMA) to "expeditiously" frame a policy for identifying those who died due to after effects of COVID-19 immunisation and compensating their dependents.
-
Death Rates Low Despite Rise In Covid Cases Due To Vaccination: Centre
The COVID-19 case trajectory in some states is witnessing an upward trend since May but hospitalisation and death rates are low which can be attributed to immunisation efforts across India, the Lok Sabha was told Friday.
-
Immunisation Panel Approves Covovax Vaccine For 12-17 Age Group: Report
National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17, said sources.
-
COVID-19 Working Group To Review Data For Covovax Vaccine On Friday: Report
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine - Covovax for use for children and adults, on April 1, sources said today.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
-
"Reports That Expired Covid Shots Being Given False, Misleading": Centre
Reports claiming that expired vaccines in the 15 to 18 age group are being given under national COVID-19 vaccination programme are false and misleading, the government clarified today, adding that the reports used "incomplete information".
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Europe Ramps Up Covid Vaccine Drive For Children Under 5 As Omicron Spreads
Europe stepped up vaccinations of children aged five to 11 against Covid-19 Wednesday, as the EU's health agency warned that immunisation alone would not stop the rapid rise of the Omicron variant of the virus.
-
Senegal Expects 400,000 Covid Vaccine Doses To Be Wasted By End-December
At least 200,000 COVID-19 vaccines have expired in Senegal without being used in the past two months and another 200,000 are set to expire at the end of December because demand is too slow, the head of its immunisation programme said on Monday.
